Cardiac Monitoring Devices Market Set to Witness Adamant US$ 43,334.36 million at CAGR of 6.4% by 2028

According to our latest market research study, titled "Global Cardiac Monitoring Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type, Product Type, Application, and End User," the cardiac monitoring devices market is expected to reach US$ 43,334.36 million by 2028 from US$ 28,098.08 million in 2021; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. The report highlights the trends prevailing in the global cardiac monitoring devices market and market drivers and deterrents. An increase in the incidence of cardiovascular diseases, the surge in the geriatric population base, and an increase in the number of product launches and approvals are driving the global cardiac monitoring devices market. However, the risk of associated cybersecurity vulnerabilities challenges is hampering the the market growth.

In the last decade, the world witnessed notable developments in cardiac monitoring devices, offering physicians and patients new approaches to manage many diseases, including atrial arrhythmias, ventricular arrhythmias, and ventricular atrial fibrillation. The growing prevalence of cardiovascular diseases (CVDs) such as coronary heart diseases, sudden cardiac arrest, congenital heart diseases, heart failure, pulmonary hypertension, and pulmonary artery pressure (PA) encourages improved monitoring methods.

Request for Sample of Cardiac Monitoring Devices Market to know which company is expected to be at the forefront in the coming years @
https://www.theinsightpartners.com/sample/TIPRE00017793/?utm_source=OpenPR&utm_medium=10411

A few of the primary risk factors of CVDs include family history, ethnicity, and age; other risk factors include tobacco consumption, hypertension, obesity, high cholesterol, physical inactivity, diabetes, unhealthy diets, and alcohol consumption. Further, lifestyle changes lead to the rise in diabetes, hypertension, dyslipidemia, and obesity, contributing to a surge in CVD cases worldwide. Most CVD cases can be prevented through proactive monitoring and early diagnosis, which bolsters the need for cardiac monitoring devices. Thus, an increase in the incidence of cardiovascular diseases drives global cardiac monitoring devices market growth.

Some of the Prominent/Emerging Players in Cardiac Monitoring Devices Market:
Medtronic; Abbott; Boston Scientific Corporation; iRhythm Technologies, Inc.; GE Healthcare; SCHILLER Healthcare India Pvt. Ltd; Koninklijke Philips N.V.; MicroPort Scientific Corporation; Asahi Kasei Corporation; Hill-Rom Holdings, Inc.; Nihon Kohden Corporation; AliveCor, Inc; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; ACS Diagnostics; BTL; Hemodynamics Company LLC; Mortara Instruments; LivaNova PLC; TZ Medical; Amiitalia; RHYTHMEDIX; and Medi-Lynx Cardiac Monitoring, LLC.

Product launches and mergers and acquisitions are the highly adopted strategies by the players operating in the global cardiac monitoring devices market. A few of the recent key product developments are listed below:

In July 2021, Abbott launched the Jot Dx insertable cardiac monitor in the US market to detect irregular heart rhythms.
In July 2021, Two AccuRhythm AI algorithms for use with the LINQ II insertable cardiac monitor (ICM) were approved by the US Food and Drug Administration (FDA) (ICM). AccuRhythm AI uses artificial intelligence (AI) to improve the accuracy of heart rhythm event data acquired by LINQ II, allowing physicians to diagnose better and treat aberrant heart rhythms.

Have Question? Speak to Analyst at:
https://www.theinsightpartners.com/speak-to-analyst/TIPRE00017793/?utm_source=OpenPR&utm_medium=10411

Cardiac Monitoring Devices - By Type
• Cardiovascular Devices
o Event Monitors
o Electrocardiography (ECG)
o Cardiac Catheters
o Stents
o Defibrillators
o Guidewires
o Pacemakers
o Heart Valves
o Others
• Patient Monitoring Devices
o Cardio Monitoring Devices
o Anesthesia Monitoring Devices
o Haemodynamic Monitoring Devices
o Fetal and Neonatal Monitoring Devices
o Stress Management Devices
 Stress Echocardiography
 Treadmill Stress Tests
 Myocardial Perfusion PET Stress Test
 Nuclear Stress Test (SPECT)
•
o Others
• Multi-Parameter ECG Monitors
• Cardiac Monitors
o Cardiac Event Monitoring (CEM)
o Holter
o Extended Holter/AECG
o Others
• Ambulatory Cardiac Monitoring
o Event Recorders
o Implantable Loop Recorders
o Mobile Cardiac Telemetry
o Others
• Others
Cardiac Monitoring Devices -
By Product Type
• Standard Monitor
• Portable Monitor
• Smart Wearable Monitor
Cardiac Monitoring Devices -
By Application
• Coronary Heart Diseases
• Stroke
• Sudden Cardiac Arrest
• Arrhythmia
• Heart Failure
• Pulmonary Hypertension
• Congenital Heart Diseases
• Pulmonary Artery Pressure (PA)
• Heart Function (HF/LVEDP)
• Others
Cardiac Monitoring Devices -
By End User
• Hospitals
• Clinics
• Ambulatory Surgery Centers
• Cardiac Centers
• Home Care
• Others

Interested in Purchasing this Report? Click here @
https://www.theinsightpartners.com/buy/TIPRE00017793/?utm_source=OpenPR&utm_medium=10411

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.